Carcinoma in Situ

This is a very early stage of cancer. It means the cancer cells are present but haven't spread outside the place they started. It's considered pre-cancer, meaning it could potentially turn into cancer if not treated.

Condition

What people with Carcinoma in Situ report

Every report comes from a Lived member, sent anonymously.

Have you had Lumpectomy for Carcinoma in Situ?

NameHow it went

About Carcinoma in Situ

What It Is

Carcinoma in situ (CIS) means abnormal cells that look like cancer cells under a microscope have been found, but they are still confined to the thin lining layer where they started. "In situ" is Latin for "in its original place." Because the cells have not grown into the surrounding tissue, CIS is also called stage 0, the earliest point on the cancer staging scale. That distinction matters. Cancer becomes dangerous when it invades nearby tissue and can reach blood vessels and lymph nodes, which is how it spreads through the body. CIS has not taken that step. Left untreated, though, some CIS can go on to become invasive cancer, and doctors currently cannot reliably tell which cases will. That is why it is usually treated rather than simply watched. Sources differ on whether to call it a cancer or a precancer: some describe it as not yet cancer, while others call breast CIS a non-invasive cancer. CIS is not one disease. It is named for the tissue where it begins, and each type behaves differently. Common examples are ductal carcinoma in situ (DCIS) in the milk ducts of the breast, severe cell changes or adenocarcinoma in situ in the cervix, squamous cell carcinoma in situ of the skin (also called Bowen's disease), and carcinoma in situ of the bladder lining. It can also occur in the mouth, larynx (voice box), lungs and digestive tract. Lobular carcinoma in situ (LCIS) of the breast, despite its name, is generally treated as a marker of higher breast cancer risk rather than as stage 0 cancer.

Causes & Risk Factors

CIS develops when changes build up in the DNA (genetic material) of cells lining an organ, causing them to grow abnormally. Often no single cause can be identified, and the main risk factors depend on where it arises. In the cervix, most abnormal cell changes are caused by infection with high-risk types of human papillomavirus (HPV), and the changes are more likely to become severe when the infection persists. On the skin, squamous cell carcinoma in situ is tied to years of sun exposure, and fair skin raises the risk. In the bladder, smoking is the major risk factor. Breast DCIS shares the risk factors of breast cancer generally, including older age, family history and inherited changes in genes such as BRCA1 and BRCA2, which normally help repair damaged DNA. Having a risk factor does not mean a person caused their CIS, and many people with these exposures never develop it.

How It's Diagnosed

CIS rarely causes symptoms, so it is most often found through screening or by checking something that looks unusual. Breast DCIS usually shows up on a mammogram. Cervical CIS is found after an abnormal Pap or HPV test leads to a closer look at the cervix. Skin CIS typically appears as a persistent scaly, dry-looking, rough patch. Bladder CIS may cause blood in the urine, a frequent urge to urinate or pain when urinating, and is found by looking inside the bladder with a thin camera (cystoscopy). A diagnosis can only be confirmed by a biopsy, in which a small sample of tissue is removed and examined by a pathologist. The pathologist looks at whether the abnormal cells have stayed within their original layer or broken through its boundary (the basement membrane). If they have broken through, the diagnosis is invasive cancer rather than CIS. The report may also describe the grade (how abnormal the cells look) and, for breast DCIS, whether the cells have hormone receptors, which affects treatment choices. Sometimes a biopsy samples only part of an area, and invasive cancer is found once the whole area is removed. This is one reason removal is often recommended even after a biopsy shows CIS.

Treatment Options

The goal of treatment is to remove or destroy the abnormal cells before they can become invasive cancer. Because CIS has not spread, treatment is usually local, aimed only at the affected area. The specific options depend on the organ. For breast DCIS, most people choose between breast-conserving surgery (lumpectomy, which removes the abnormal area with a margin of healthy tissue) and mastectomy, removal of the breast. Lumpectomy is usually followed by radiation to lower the chance of DCIS or invasive cancer returning in that breast. Mastectomy may be recommended when DCIS is large or in several areas. If the DCIS has hormone receptors, about five years of hormone therapy, such as tamoxifen or, after menopause, an aromatase inhibitor, can lower the risk of a new DCIS or invasive cancer in either breast; its side effects are weighed against that benefit. Studies are testing whether close monitoring alone is safe for some low-risk DCIS, but that is not yet standard care. For cervical CIS, the abnormal area is removed, most often with a loop electrosurgical excision procedure (LEEP), which uses a thin heated wire loop, or a cone biopsy that removes a cone-shaped piece of tissue. Pregnancy can change the timing of treatment. For skin CIS, a dermatologist can usually treat it in the office by cutting it out, scraping and cauterizing it, freezing it with liquid nitrogen, or with photodynamic therapy, which uses a light-activated medicine applied to the skin. Skin CIS is highly treatable. Bladder CIS is treated differently because it is high grade and tends to come back. After visible tumors are removed through the urethra, treatment usually involves BCG (bacillus Calmette-Guérin), a weakened bacterium placed directly into the bladder through a catheter that triggers an immune response against the abnormal cells. It is typically given weekly for six weeks, then less often for up to three years. If BCG does not work, options include other medicines placed in the bladder, immunotherapy, or surgery to remove the bladder.

What to Expect

For most types of CIS, the outlook after treatment is very good, because the abnormal cells are removed before they have had a chance to invade or spread. Many treatments are outpatient procedures with a short recovery. A diagnosis of stage 0 can still bring real worry and difficult decisions, especially for breast DCIS, where people weigh surgery types, radiation and hormone therapy. CIS can come back in the same place, and having had it can signal a higher chance of a new problem in the same organ. Follow-up is therefore an important part of care, and its intensity depends on the type. After breast DCIS, people continue regular mammograms and check-ups. After cervical CIS, repeat HPV and Pap testing checks that the changes have not returned. After skin CIS, regular full-body skin exams look for new spots. Bladder CIS needs the closest watch: cystoscopy about every three months for at least the first couple of years, because it has a higher chance of returning, sometimes as a more serious cancer that grows into the bladder wall. Reducing ongoing risk factors, such as quitting smoking for bladder CIS or protecting skin from the sun for skin CIS, can lower the chance of new problems.

When to Seek Help

Arrange an evaluation if a screening test such as a mammogram or Pap test comes back abnormal, or if you notice a skin patch that is scaly, growing or not healing over several weeks. Keep scheduled follow-up appointments after treatment even when you feel well, since recurrence usually causes no symptoms at first. Contact your care team promptly about a change in the treated area or in the same organ: a new breast lump or nipple change, blood in the urine, abnormal vaginal bleeding, or a skin spot that bleeds, grows or returns. During BCG treatment for bladder CIS, mild flu-like symptoms for a day or two are common. Call the team right away for a fever of 103°F or higher, flu-like symptoms lasting more than three days, or symptoms that get stronger with each treatment, since these can signal a BCG infection that needs treatment.

Questions to Ask Your Doctor

  1. 1.Where exactly is my carcinoma in situ, what grade is it, and how confident are you that there is no invasive cancer?
  2. 2.What are my treatment options, and how do they compare in recurrence risk, recovery and side effects?
  3. 3.Is close monitoring instead of treatment ever reasonable for my type, or is treatment clearly the better choice?
  4. 4.What follow-up tests will I need after treatment, and how often?
  5. 5.Are there steps I can take, or genetic testing I should consider, to lower my risk of this coming back or of a new cancer?

Last reviewed • Oct 2026

Educational content, not medical advice.